Results 111 to 120 of about 63,993 (197)

Estriol Is Likely Not Associated With Mouth Ulcerations in Pharmacovigilance Data. [PDF]

Int Dent J
Böhm R, Herdegen T.
europepmc   +1 more source

Correction: Model estimates of hospitalization discharge rates for norovirus gastroenteritis in Europe, 2004–2015

BMC Infectious Diseases
Elsa Negro-Calduch, Tom Cattaert, Thomas Verstraeten   +2 more
doaj   +1 more source

Performance of active drug safety monitoring and management for pharmacovigilance strengthening in Ethiopia, experience from a multidrug-resistant tuberculosis management program: a cross-sectional study. [PDF]

BMJ Open
Achalu DL, Meshesha SG, Kiltu AB, Wendimu DE, Tegegne NA, Alemu A, Tiemersma EW, Cobelens F, Teferi M.   +8 more
europepmc   +1 more source

Global Pharmacovigilance of Aesthetic Botulinum Toxin Type A: Analysis of Adverse Event Reports From the USA, Europe, Canada, and Australia. [PDF]

J Cosmet Dermatol
Zargaran A, Zargaran D, Pirayesh A, Woollard A, Mosahebi A.   +4 more
europepmc   +1 more source

Ecopharmacovigilance and pharmacovigilance: an analysis of environment-related reporting in VigiBase. [PDF]

Environ Sci Pollut Res Int
Mitchell J, Maza Larrea J, Dzidzornu ED, Pandit J, Cherian JJ, Massouh R.   +5 more
europepmc   +1 more source

The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice. [PDF]

J Clin Tuberc Other Mycobact Dis
Lamba P.
europepmc   +1 more source

Reclaiming Pharmacovigilance: Bridging the Evidence-Practice Gap in Psychopharmacology. [PDF]

J Eval Clin Pract
De Las Cuevas C.
europepmc   +1 more source

Comparison of pharmacovigilance and mechanism analysis of the vascular toxicity caused by platin-based chemotherapy: integration of FAERS analysis, network pharmacology, and endothelial validation. [PDF]

Ther Adv Drug Saf
Chen Y, Wang C, Jiang P, Chen Y, Zhang T, Cai S.   +5 more
europepmc   +1 more source

Immune Checkpoint Inhibitor-Associated Immune-Mediated Nephropathy: A Real-World Pharmacovigilance Study. [PDF]

J Clin Med
Mutis Alan A, Murt A, Dinçer MT, Trabulus S, Alan Ö, Altiparmak MR.   +5 more
europepmc   +1 more source

Early Evaluation of the Food and Drug Administration (FDA) Adverse Event Monitoring System (AEMS): An Analysis of Over 32 Million Pharmacovigilance Reports. [PDF]

Cureus
Lakhan SE.
europepmc   +1 more source